Profound neurological illness, relieved by protein restriction, in a baby with a transient disturbance in the metabolism of ingested isoleucine.
An 8-month-old infant presented because of poor development followed by the acute onset of cortical blindness and a severe seizure disorder at the time of changing from breast to formula feeding. Metabolic investigations revealed an increased urinary excretion of 2-methyl-3-hydroxybutyric, methylmalonic and 2-ethylhydracrylic acids. The concentration of these compounds in urine was augmented by oral protein (5 g/kg per day) and isoleucine loading. A low protein diet (1.5 g/kg per day) produced a dramatic response with complete cessation of seizures and a marked improvement in vision and general development. After many months of low protein diet, the biochemical abnormalities were no longer detectable, even after protein loading. Extensive investigations have failed to reveal an intrinsic enzyme defect which would account for these clinical and biochemical findings. A toxic effect of a bacterial metabolite of isoleucine is proposed.
D000592:Amino Acid Metabolism, Inborn Errors / Q000178:diet therapy* / Q000235:genetics; D002658:Developmental Disabilities / Q000178:diet therapy; D004044:Dietary Proteins / Q000008:administration & dosage*; D004827:Epilepsy / Q000178:diet therapy; D005260:Female; D006801:Humans; D007223:Infant; D007532:Isoleucine / Q000378:metabolism*; D009123:Muscle Hypotonia / Q000178:diet therapy; D009422:Nervous System Diseases / Q000178:diet therapy* / Q000235:genetics
D004044:Dietary Proteins; D007532:Isoleucine